相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Efficacy and safety of anti-inflammatory agents for the treatment of major depressive disorder: a systematic review and meta-analysis of randomised controlled trials
Shuang Bai et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2020)
Neurotrophic mechanisms underlying the rapid and sustained antidepressant actions of ketamine
Satoshi Deyama et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2020)
Anti-inflammatory Strategies for Schizophrenia: A Review of Evidence for Therapeutic Applications and Drug Repurposing
Jonghee Hong et al.
CLINICAL PSYCHOPHARMACOLOGY AND NEUROSCIENCE (2020)
Peripheral vascular endothelial growth factor changes after transcranial magnetic stimulation in treatment-resistant depression
Andrew M. Fukuda et al.
NEUROREPORT (2020)
Elevated serum vascular endothelial growth factor in treatment-resistant schizophrenia treated with electroconvulsive therapy: Positive association with therapeutic effects
Wenhuan Xiao et al.
WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY (2019)
Treatment resistant schizophrenia: Clinical, biological, and therapeutic perspectives
Frederick C. Nucifora et al.
NEUROBIOLOGY OF DISEASE (2019)
Repetitive transcranial magnetic stimulation (rTMS) fails to increase serum brain-derived neurotrophic factor (BDNF)
Binghu Jiang et al.
NEUROPHYSIOLOGIE CLINIQUE-CLINICAL NEUROPHYSIOLOGY (2019)
Clinical guidelines for the management of treatment-resistant depression: French recommendations from experts, the French Association for Biological Psychiatry and Neuropsychopharmacology and the fondation FondaMental
L. D. Bennabi et al.
BMC PSYCHIATRY (2019)
Inflammation-related biomarkers in major psychiatric disorders: a cross-disorder assessment of reproducibility and specificity in 43 meta-analyses
Ning Yuan et al.
TRANSLATIONAL PSYCHIATRY (2019)
Interaction of BDNF and cytokines in executive dysfunction in patients with chronic schizophrenia
Mei Hong Xiu et al.
PSYCHONEUROENDOCRINOLOGY (2019)
Neurotrophic and Antidepressant Actions of Brain-Derived Neurotrophic Factor Require Vascular Endothelial Growth Factor
Satoshi Deyama et al.
BIOLOGICAL PSYCHIATRY (2019)
Association of baseline inflammatory markers and the development of negative symptoms in individuals at clinical high risk for psychosis
David R. Goldsmith et al.
BRAIN BEHAVIOR AND IMMUNITY (2019)
Repetitive transcranial magnetic stimulation increases serum brain-derived neurotrophic factor and decreases interleukin-1β and tumor necrosis factor-α in elderly patients with refractory depression
Xiangxiang Zhao et al.
JOURNAL OF INTERNATIONAL MEDICAL RESEARCH (2019)
Lipid Peroxidation and Immune Biomarkers Are Associated with Major Depression and Its Phenotypes, Including Treatment-Resistant Depression and Melancholia
Magdalena Sowa-Kucma et al.
NEUROTOXICITY RESEARCH (2018)
VEGF - A Stimulus for Neuronal Development and Regeneration in the CNS and PNS
Verena Theis et al.
CURRENT PROTEIN & PEPTIDE SCIENCE (2018)
Baseline serum vascular endothelial growth factor levels predict treatment response to antipsychotic medication in patients with schizophrenia
Wenhuan Xiao et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2018)
Low tumor necrosis factor-α levels predict symptom reduction during electroconvulsive therapy in major depressive disorder
Annamari Sorri et al.
BRAIN AND BEHAVIOR (2018)
Brain-Derived Neurotrophic Factor and Major Depressive Disorder: Evidence from Meta-Analyses
Taro Kishi et al.
FRONTIERS IN PSYCHIATRY (2018)
Decreased peripheral TNF alpha (TNF-alpha) mRNA expression in patients with treatment-resistant schizophrenia
Md Shaki Mostaid et al.
SCHIZOPHRENIA RESEARCH (2018)
TNF-α and IL-6 are associated with the deficit syndrome and negative symptoms in patients with chronic schizophrenia
David R. Goldsmith et al.
SCHIZOPHRENIA RESEARCH (2018)
Growth Factor Proteins and Treatment-Resistant Depression: A Place on the Path to Precision
Alice Pisoni et al.
FRONTIERS IN PSYCHIATRY (2018)
Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017
Spencer L. G. James et al.
LANCET (2018)
BDNF: A Key Factor with Multipotent Impact on Brain Signaling and Synaptic Plasticity
Przemyslaw Kowianski et al.
CELLULAR AND MOLECULAR NEUROBIOLOGY (2018)
High-Frequency Repetitive Transcranial Magnetic Stimulation (rTMS) Improves Functional Recovery by Enhancing Neurogenesis and Activating BDNF/TrkB Signaling in Ischemic Rats
Jing Luo et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
Using blood cytokine measures to define high inflammatory biotype of schizophrenia and schizoaffective disorder
Danny Boerrigter et al.
JOURNAL OF NEUROINFLAMMATION (2017)
Using neuroimaging to individualize TMS treatment for depression: Toward a new paradigm for imaging-guided intervention
Bruce M. Luber et al.
NEUROIMAGE (2017)
The serum protein levels of the tPA-BDNF pathway are implicated in depression and antidepressant treatment
H. Jiang et al.
TRANSLATIONAL PSYCHIATRY (2017)
Altered peripheral immune profiles in treatment-resistant depression: response to ketamine and prediction of treatment outcome
D. D. Kiraly et al.
TRANSLATIONAL PSYCHIATRY (2017)
Association of serum VEGF levels with prefrontal cortex volume in schizophrenia
A. Pillai et al.
MOLECULAR PSYCHIATRY (2016)
Increased serum brain-derived neurotrophic factor levels following electroconvulsive therapy or antipsychotic treatment in patients with schizophrenia
J. Li et al.
EUROPEAN PSYCHIATRY (2016)
Serum levels of brain-derived neurotrophic factor (BDNF), proBDNF and plasma 3-methoxy-4-hydroxyphenylglycol levels in chronic schizophrenia
Reiji Yoshimura et al.
ANNALS OF GENERAL PSYCHIATRY (2016)
The reduction of CSF tumor necrosis factor alpha levels in schizophrenia: no correlations with psychopathology and coincident metabolic characteristics
Haibing Zhu et al.
NEUROPSYCHIATRIC DISEASE AND TREATMENT (2016)
Treatment-resistant schizophrenia: current insights on the pharmacogenomics of antipsychotics
John Lally et al.
PHARMACOGENOMICS & PERSONALIZED MEDICINE (2016)
IL-6, IL-18, sIL-2R, and TNFα proinflammatory markers in depression and schizophrenia patients who are free of overt inflammation
Hussein Kadhem Al-Hakeim et al.
JOURNAL OF AFFECTIVE DISORDERS (2015)
Lower Brain-Derived Neurotropic Factor Levels in Untreated Adolescents With First-Episode Psychosis
Seref Simsek et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2015)
Alterations in plasma vascular endothelial growth factor levels in patients with schizophrenia before and after treatment
Bun-Hee Lee et al.
PSYCHIATRY RESEARCH (2015)
Expression and interaction of TNF-α and VEGF in chronic stress-induced depressive rats
Baohua Li et al.
EXPERIMENTAL AND THERAPEUTIC MEDICINE (2015)
BDNF blood levels after non-invasive brain stimulation interventions in major depressive disorder: A systematic review and meta-analysis
Andre R. Brunoni et al.
WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY (2015)
Association between baseline serum vascular endothelial growth factor levels and response to electroconvulsive therapy
A. Minelli et al.
ACTA PSYCHIATRICA SCANDINAVICA (2014)
Biological Markers in Noninvasive Brain Stimulation Trials in Major Depressive Disorder: A Systematic Review
Thiago M. Fidalgo et al.
JOURNAL OF ECT (2014)
Decreased peripheral brain-derived neurotrophic factor levels are a biomarker of disease activity in major psychiatric disorders: a comparative meta-analysis
B. S. Fernandes et al.
MOLECULAR PSYCHIATRY (2014)
VEGF ligands and receptors: implications in neurodevelopment and neurodegeneration
Peter Carmeliet et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2013)
Role of activity-dependent BDNF expression in hippocampal-prefrontal cortical regulation of behavioral perseverance
Kazuko Sakata et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Efficacy of Transcranial Magnetic Stimulation Targets for Depression Is Related to Intrinsic Functional Connectivity with the Subgenual Cingulate
Michael D. Fox et al.
BIOLOGICAL PSYCHIATRY (2012)
TNF-α-Induced VEGF and MMP-9 Expression Promotes Hemorrhagic Transformation in Pituitary Adenomas
Zhengzheng Xiao et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2011)
Vascular Endothelial Growth Factor (VEGF) serum concentration during electroconvulsive therapy (ECT) in treatment resistant depressed patients
Alessandra Minelli et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2011)
Raised plasma levels of tumor necrosis factor α in patients with depression -: Normalization during electroconvulsive therapy
KA Hestad et al.
JOURNAL OF ECT (2003)
分享论文
